Fact CheckerSign in

NCT06043401Active, not recruiting

Tracking Brain Biomarkers and Renormalization Associated With Antidepressant Transcranial Magnetic Stimulation Therapy

Source: ClinicalTrials.gov · Last updated 20 Apr 2026

Brief summary (registry, in English)

This study will attempt to use magnetic resonance imaging (MRI) to take a picture of the brain to learn about changes that occur in the brain during Transcranial Magnetic Stimulation (TMS) in people receiving this treatment for depression.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
16 Aug 2023
Start date
4 Apr 2023
Primary completion date
1 Apr 2027
Lead sponsor
Medical University of South Carolina
Diseases
Depression
NCT number
NCT06043401

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 4 Apr 2023 to the primary completion date, 1 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any current or recent untreated medical, neurological, or psychiatric conditions other than MDD that would preclude candidacy for TMS.
  • Metal implant devices in the head, heart, or neck.
  • History of brain surgery.
  • History of cortisol medication use or electroconvulsive therapy.
  • History of myocardial infarction or arrhythmia, bradycardia.
  • Personal history of recent head injury, concussion, or self-report of moderate to severe traumatic brain injury.
  • Moderate to severe alcohol or substance use disorder.
  • Any current or recent untreated medical, neurological, or psychiatric conditions
  • Metal implant devices in the head, heart, or neck.
  • History of brain surgery.
  • History of cortisol medication use or electroconvulsive therapy.
  • Comorbidity with other psychiatric/neurological illnesses or personality disorders
  • History of myocardial infarction or arrhythmia, bradycardia.
  • Personal history of recent head injury, concussion, or self-report of moderate to severe traumatic brain injury.
  • Moderate to severe alcohol or substance use disorder.

Age

  • Age 18-65

Other

  • Unable to speak English.
  • Contraindicated for MRI.
  • Individuals suffering from frequent/severe headaches.
  • Pregnancy
    • Healthy Volunteers Inclusion Criteria
  • Have the capacity and ability to provide one's own consent in English and sign the informed consent document.
  • Unable to speak English.
  • Contraindicated for MRI.
  • Individuals suffering from frequent/severe headaches.
  • Pregnancy

Who the study is looking for

  • Age 18-65
  • Have the capacity and ability to provide one's own consent in English and sign the informed consent document.
  • DSM-IV diagnosis of MDD

Criteria the registry did not label

  • MDD volunteers:

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.